C. Chaignot

761 total citations · 1 hit paper
13 papers, 534 citations indexed

About

C. Chaignot is a scholar working on Neurology, Epidemiology and Surgery. According to data from OpenAlex, C. Chaignot has authored 13 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 5 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in C. Chaignot's work include Peripheral Neuropathies and Disorders (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). C. Chaignot is often cited by papers focused on Peripheral Neuropathies and Disorders (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). C. Chaignot collaborates with scholars based in France, Russia and Morocco. C. Chaignot's co-authors include Alain Weill, François Alla, P. Ricordeau, Pierre‐Olivier Blotière, Aurélie Bannay, Mickaël Basson, Rosemary Dray‐Spira, Mahmoud Zureik, C. Collin and Françis Bolgert and has published in prestigious journals such as PLoS ONE, Medical Care and Vaccine.

In The Last Decade

C. Chaignot

12 papers receiving 530 citations

Hit Papers

The Best Use of the Charlson Comorbidity Index With Elect... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Chaignot France 8 151 117 93 62 59 13 534
Aurélie Bannay France 7 131 0.9× 102 0.9× 46 0.5× 63 1.0× 93 1.6× 17 485
Jared Davis United States 6 86 0.6× 129 1.1× 33 0.4× 55 0.9× 55 0.9× 18 455
Bernhard Kumle Germany 13 143 0.9× 128 1.1× 64 0.7× 31 0.5× 96 1.6× 67 717
GIL HAUGH United States 4 82 0.5× 87 0.7× 31 0.3× 48 0.8× 47 0.8× 4 399
Stuart McKechnie United Kingdom 14 192 1.3× 133 1.1× 66 0.7× 51 0.8× 115 1.9× 38 800
C. Gastaldi‐Ménager France 4 144 1.0× 92 0.8× 30 0.3× 76 1.2× 69 1.2× 17 612
S. Guillo France 9 155 1.0× 163 1.4× 30 0.3× 53 0.9× 92 1.6× 29 470
Sanghyun Kim South Korea 6 90 0.6× 82 0.7× 27 0.3× 32 0.5× 57 1.0× 10 556
Yanfei Shen China 11 196 1.3× 139 1.2× 52 0.6× 73 1.2× 133 2.3× 50 530
Rahul Mainra Canada 14 78 0.5× 107 0.9× 57 0.6× 45 0.7× 164 2.8× 38 662

Countries citing papers authored by C. Chaignot

Since Specialization
Citations

This map shows the geographic impact of C. Chaignot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Chaignot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Chaignot more than expected).

Fields of papers citing papers by C. Chaignot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Chaignot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Chaignot. The network helps show where C. Chaignot may publish in the future.

Co-authorship network of co-authors of C. Chaignot

This figure shows the co-authorship network connecting the top 25 collaborators of C. Chaignot. A scholar is included among the top collaborators of C. Chaignot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Chaignot. C. Chaignot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Chaignot, C., Mahmoud Zureik, Grégoire Rey, et al.. (2018). Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France. Pharmacoepidemiology and Drug Safety. 27(11). 1239–1248. 29 indexed citations
3.
4.
Maura, Géric, C. Chaignot, Alain Weill, François Alla, & Isabelle Heard. (2017). Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study. European Journal of Cancer Prevention. 27(5). 479–485. 13 indexed citations
5.
Rudant, Jérémie, et al.. (2017). Incidence du syndrome de Guillain-Barré en France : une analyse épidémiologique à partir des données du PMSI (2008–2013). Revue d Épidémiologie et de Santé Publique. 65. S7–S7. 1 indexed citations
6.
Rudant, Jérémie, et al.. (2016). Guillain‐Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008–2013). Journal of the Peripheral Nervous System. 22(1). 51–58. 35 indexed citations
7.
Chaignot, C., et al.. (2016). Vaccination anti-HPV et risque de maladies auto-immunes : étude de cohorte française. Revue d Épidémiologie et de Santé Publique. 64. S10–S10. 2 indexed citations
8.
Roussel, Ronan, C. Chaignot, Alain Weill, et al.. (2015). Use of Fibrates Monotherapy in People with Diabetes and High Cardiovascular Risk in Primary Care: A French Nationwide Cohort Study Based on National Administrative Databases. PLoS ONE. 10(9). e0137733–e0137733. 11 indexed citations
9.
Chaignot, C., Alain Weill, P. Ricordeau, & François Alla. (2015). Utilisation en France du baclofène dans l’alcoolodépendance de 2007 à 2013 : étude à partir du SNIIRAM et du PMSI. Therapies. 70(5). 443–453. 27 indexed citations
10.
Bannay, Aurélie, C. Chaignot, Pierre‐Olivier Blotière, et al.. (2015). The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality. Medical Care. 54(2). 188–194. 329 indexed citations breakdown →
11.
Bannay, Aurélie, C. Chaignot, Pierre‐Olivier Blotière, et al.. (2014). Système national d’information inter-régimes de l’assurance maladie (Sniiram) chaîné au Programme de médicalisation des systèmes d’information (PMSI) et score de Charlson. Revue d Épidémiologie et de Santé Publique. 62. S124–S124. 3 indexed citations
12.
Chaignot, C., et al.. (2013). Score de Charlson à partir des données du Sniiram chaînées au PMSI : faisabilité et valeur pronostique sur la mortalité à un an. Revue d Épidémiologie et de Santé Publique. 61. S9–S9. 9 indexed citations
13.
Chaignot, C., Alain Weill, Pierre‐Olivier Blotière, et al.. (2013). Intérêt de l’identifiant bénéficiaire anonyme unique vie entière dans le Sniiram et de son utilisation après chaînage dans le PMSI. Revue d Épidémiologie et de Santé Publique. 61. S16–S16. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026